Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
Manufacturer: Novo Nordisk India Pvt Ltd
Disease(s): Type 2 Diabetes Mellitus / High Blood Sugar
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.
A generic drug is made with the same active ingredients and is available in thesame strength and dosage form as the equivalent brand-name product. Generic drugs produce the same effects in the body as the brand-name drugs, because both contain the identical active ingredients...
Albania
Algeria
Andorra
Argentina
Australia
Austria
Bahamas
Bahrain
Barbados
Belgium
Bermuda
Bosnia And Herzegovina
Brazil
British Indian Ocean Territory
Bulgaria
Canada (english)
Cayman Islands
Chile
Christmas Island
Colombia
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Cuba
Cyprus
Czech Republic
Denmark
Deutschland
Dominican Republic
Ecuador
Egypt
Eritrea
Estonia
European union
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Georgia
Greece
Greenland
Guadeloupe
Guam
Haiti
Heard Island and Mcdonald Islands
Holy See (Vatican City State)
Hong Kong
Iceland
Indonesia
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Korea, Republic of
Latvia
Liechtenstein
Luxemburg
Macedonia
Madagascar
Malaysia
Maldives
Malta
Marshall Islands
Martinique
Mayotte
Mexico
Moldova
Monaco
Mongolia
Morocco
Netherlands Antilles
New Caledonia
New Zealand
Nigeria
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
San Marino
Sao Tome and Principe
Seychelles
Singapore
Slovakia
Slovenia
Solomon Islands
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Taiwan, Province of China
Thailand
The Nederlands
Tunisia
Turks and Caicos Islands
United Kingdom
United States
United States Minor Outlying Islands
Venezuela
Vietnam
Virgin Islands, British
Virgin Islands, U.s.
Yemen
Croatia
Hungary
By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.